Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3921 - 3928 of 11616 results
COVID-19 and GDPR Obligations for Companies
April 6, 2020| News
Pandemic Creates Roadblocks During H-1B Visa Cycle
April 6, 2020| News
M&A in the COVID Era – Part II – Debt Financing Opportunities for Middle Market PE Funds
April 6, 2020| Advisory| Viewpoint
FINRA Posts Additional Cybersecurity Alert in Response to COVID-19
April 6, 2020| Blog| Viewpoint
Virus No 'Excuse' to Delay CCPA, Says California Senator; AG Sticks With July 1
April 6, 2020| News
U.S. Department of Justice Issues First COVID-19-Related Business Review Letter to Medical Supplies Distributors
April 6, 2020| Blog| Viewpoint
ML Strategies COVID-19 Insights Week In Review — April 3, 2020
April 3, 2020| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.